HbA1c and peripheral arterial disease in diabetes -: The atherosclerosis risk in communities study

被引:133
作者
Selvin, E
Wattanakit, K
Steffes, MW
Coresh, J
Sharrett, AR
机构
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21218 USA
[3] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA
[4] Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA
关键词
D O I
10.2337/diacare.29.04.06.dc05-2018
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - To assess the relation between HbA(1c) (A1C) and incident peripheral arterial disease (PAD) in a community-based cohort of diabetic adults from the Atherosclerosis Risk in Communities (ARIC) study. A second aim was to investigate whether the association was stronger for severe, symptomatic disease compared with PAD assessed by low ankle-brachial index (ABI). RESEARCH DESIGN AND METHODS - This was a prospective cohort study of 1,894 individuals With diabetes using ARIC visit 2 as baseline (1990-1992) with follow-up for incident PAD through 2002. We assessed the relation between A1C and incident PAD, defined by intermittent claudication, PAD-related hospitalization, or a low ABI (< 0.9). RESULTS - During a mean follow-up of 9.8 years, the crude incidence rates were 2.1 per 1,000 person-years for intermittent. Claudication (n = 41), 2.9 per 1,000 person-years for PAD-related hospitalization (n = 57), and 18.9 per 1,000 person-years for low ABI at visit 3 or 4 (n = 123). The relative risk (RR) (95% CI) of an incident PAD event comparing the second and third tertiles of A1C to the First, respectively, after adjustment for cardiovascular risk factors was strongest for severe, symptomatic forms of disease, e.g., PAD-related hospitalization (RR = 4.56 [1.86-11.18] for the third A1C tertile compared with the first, P trend < 0.001) than for low ABI (RR = .1 64 [0.94-2.87], P trend = 0.08). CONCLUSIONS - We found a positive, graded, and independent association between A1C and PAD risk in diabetic adults. This association was stronger for clinical (symptomatic) PAD, whose manifestations may be related to microvascular insufficiency, than for low ABI. Our results suggest that efforts to improve glycemic control in persons with diabetes may substantially reduce the risk of PAD.
引用
收藏
页码:877 / 882
页数:6
相关论文
共 32 条
[1]   UKPDS 59: Hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes [J].
Adler, AI ;
Stevens, RJ ;
Neil, A ;
Stratton, IM ;
Boulton, AJM ;
Holman, RR .
DIABETES CARE, 2002, 25 (05) :894-899
[2]  
*ARIC, ATH RISK COMM STUD M
[3]  
*ARIC, 1987, ATH RISK COMM STUD M
[4]  
*ARIC COORD CTR, 1987, 2 U N CAR SCH PUBL C
[5]   THE SENSITIVITY, SPECIFICITY, AND PREDICTIVE VALUE OF TRADITIONAL CLINICAL-EVALUATION OF PERIPHERAL ARTERIAL-DISEASE - RESULTS FROM NONINVASIVE TESTING IN A DEFINED POPULATION [J].
CRIQUI, MH ;
FRONEK, A ;
KLAUBER, MR ;
BARRETTCONNOR, E ;
GABRIEL, S .
CIRCULATION, 1985, 71 (03) :516-522
[6]   MORTALITY OVER A PERIOD OF 10 YEARS IN PATIENTS WITH PERIPHERAL ARTERIAL-DISEASE [J].
CRIQUI, MH ;
LANGER, RD ;
FRONEK, A ;
FEIGELSON, HS ;
KLAUBER, MR ;
MCCANN, TJ ;
BROWNER, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (06) :381-386
[7]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[8]   Prevalence of lower-extremity disease in the US adult population ≥40 years of age with and without diabetes -: 1999-2000 National Health and Nutrition Examination Survey [J].
Gregg, EW ;
Sorlie, P ;
Paulose-Ram, R ;
Gu, QP ;
Eberhardt, MS ;
Wolz, M ;
Burt, V ;
Curtin, L ;
Engelgau, M ;
Geiss, L .
DIABETES CARE, 2004, 27 (07) :1591-1597
[9]   Differences between respondents and nonrespondents in a multicenter community-based study vary by gender and ethnicity [J].
Jackson, R ;
Chambless, LE ;
Yang, K ;
Byrne, T ;
Watson, R ;
Folsom, A ;
Shahar, E ;
Kalsbeek, W .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1996, 49 (12) :1441-1446
[10]   Risk factors predicting lower extremity amputations in patients with NIDDM [J].
Lehto, S ;
Pyorala, K ;
Ronnemaa, T ;
Laakso, M .
DIABETES CARE, 1996, 19 (06) :607-612